Navigation Links
MGC Diagnostics Corporation Reports 2013 Second Quarter Operating Results
Date:5/30/2013

SAINT PAUL, Minn., May 30, 2013 /PRNewswire/ -- MGC Diagnostics Corporation (NASDAQ: MGCD) (formerly Angeion Corporation), a global medical technology company, today reported financial results for the second quarter ended April 30, 2013.

(Logo: http://photos.prnewswire.com/prnh/20120821/LA60189LOGO)

Second Quarter Highlights:

  • Robust second quarter revenue of $7.6 million, an increase of 35% over the fiscal 2012 second quarter. Sequential quarterly revenue growth of 8% from the first quarter of fiscal 2013;
  • Net income for the second quarter was $252,000, or $0.06 per diluted share, compared to a net loss of $409,000, or ($0.11) per diluted share in the 2012 second quarter;
  • Group Purchasing Organization ("GPO") sales increased 69% to $3.9 million, compared to $2.3 million in the 2012 second quarter;
  • Second quarter service revenue increased 8% on a year-over-year basis, while service gross margin improved to 70.3%, compared to 64.2% in the fiscal 2012 second quarter; 
  • Gross margin in the second quarter improved 210 basis points to 55.7%, compared to 53.6% in last year's second quarter;
  • The Attachment Rate of extended service contracts sold at the point of system sale improved to 27.4%, compared to 6.2% in last year's second quarter;
  • Second quarter 2013 recurring revenue (service and supplies revenues) totaled $2.6 million, or 35% of total second quarter revenue;
  • The Company declared and paid a special, one-time cash dividend of $0.45 per share during the quarter;
  • Strong balance sheet with $8.2 million in cash and cash equivalents, $12.4 million of working capital and no long-term debt after payment of the $1.8 million dividend;
  • At April 30, 2013, the Company had federal net operating loss carry f
    '/>"/>

  • SOURCE MGC Diagnostics Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Apnix Sleep Diagnostics Announces New Houston Sleep Apnea Treatments
    2. Alzheimer Market: Drugs, Therapeutics & Diagnostics Research Reports
    3. MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013
    4. Exosome Diagnostics Presents Data Demonstrating Utility of Urine Exosome Technology to Predict Prostate Biopsy Outcome at American Urological Association Annual Meeting
    5. Algeta and Lumiphore Announce Further Expansion of Their Global Partnership for the Development of Targeted Alpha-pharmaceutical Cancer Therapeutics and Companion Diagnostics.
    6. BD Diagnostics Advances Commitment to a Fully Integrated Microbiology Solution with New Agreement
    7. Apnix Sleep Diagnostics Offering New Home Sleep Study Materials
    8. LamdaGen Corporation Issued United States Patent for Diagnostics on Plasmonic-Based Nanosensors
    9. Nipro Diagnostics Leverages Managed IT Services from JDL Technologies to Support Growth and Technological Innovation
    10. 2013 Cancer Diagnostics Market Analysis: Cancer Testing Industry Growing Rapidly
    11. Quest Diagnostics Reports First Quarter 2013 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/30/2015)... -- Pulse Light Clinic in London,s ... as part of their ongoing research into the condition. They ... their Rosacea. The survey participants were aged between 20 and ... women. The results revealed some rather surprising statistics: ... attempt to visit their GP for Rosacea treatment. ...
    (Date:6/30/2015)... 30, 2015 First Choice Wellness Care recently ... Duality and is the only clinic in the greater ... removal treatments. The practice has recently expanded their services ... to showcase their focus in the procedure. They upgraded ... faster ink clearance, and superior service. "We,ve ...
    (Date:6/30/2015)... 2015  Avanir Pharmaceuticals, Inc. today announced top-line ... treatment with NUEDEXTA ® was associated with ... affect (PBA) in patients with traumatic brain injury ... characterized by sudden and uncontrollable outbursts of laughing ... brain injury. PRISM II is a phase IV ...
    Breaking Medicine Technology:84% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7
    ... 2011 Fuisz ( www.fuisz.com ) today announced the ... Permitting Stage Door Access to On-Line Vendor Information"). ... "This patent covers a system that allows a customer ... a product supplier database through the on-line vendor,s system ...
    ... 15, 2011 Cardium Therapeutics (NYSE Amex: ... from the Russian Ministry of Health and Social Development ... Company,s Generx™ (alferminogene tadenovec, Ad5FGF-4) biologic product candidate.  Generx ... for the potential treatment of myocardial ischemia due to ...
    Cached Medicine Technology:Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 2Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 3Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 4Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 5Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 6Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 7
    (Date:6/30/2015)... Louis, MO (PRWEB) , ... June 30, 2015 ... ... attorneys handling national testosterone claims alleging heart attack and stroke incidents are linked ... after Independence Day. The Case Management Conference is scheduled for July 9, 2015, ...
    (Date:6/30/2015)... ... June 30, 2015 , ... India Network Foundation today ... for its visitor health insurance plans that provides coverage for visitors to the United ... to enable visitors to obtain services from most experienced health care professional close to ...
    (Date:6/30/2015)... ... June 30, 2015 , ... Under Armour’s new baselayer for ... than any other padding in football. , Developed in partnership with D3O®, a ... Armour is engineered with D3O protective polymer. This radical polymer material has a ...
    (Date:6/30/2015)... ... ... Isabel Healthcare announced today that it will donate the use of the ... Free Health Clinic. The Isabel diagnosis decision support solution will be used ... their perspective while working up their patients. Isabel will also provide contextual links ...
    (Date:6/30/2015)... Las Vegas, NV (PRWEB) , ... June 30, ... ... has recently returned to the U.S. after a 5-day tour in India. ... that are currently collaborating with Trivedi Master Wellness™ and Transformational Leader/Internationally ...
    Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 2Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 3Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 4Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 2Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 3Health News:Under Armour Launches Advanced Gameday Armour® Max Protection System For The Gridiron 2Health News:Isabel Healthcare Donates Differential Diagnosis Decision Support Tool to That Neighborhood Foundation 2Health News:Isabel Healthcare Donates Differential Diagnosis Decision Support Tool to That Neighborhood Foundation 3Health News:Trivedi Global Inc. CEO Visits India to Finalize Science Projects to Create Anti-Aging, Overall Health and Probiotic Products with Help of a Multi-Billion Dollar Company 2Health News:Trivedi Global Inc. CEO Visits India to Finalize Science Projects to Create Anti-Aging, Overall Health and Probiotic Products with Help of a Multi-Billion Dollar Company 3
    ... rise in developing countries and there is a significant ... safety. Many facilities in these countries lack the concept ... at a higher risk of developing complications due to ... study performed by the International Atomic Energy Agency in ...
    ... should recommend low to moderate levels of exercise to ... prior to pregnancy, states a report published in the ... American Academy of Orthopaedic Surgeons (JAAOS). According ... overall musculoskeletal and physiologic health as well as pregnancy ...
    ... team of researchers has identified a new method for ... new areas for drug development in melanoma a ... Researchers from Virginia Commonwealth University, in collaboration with ... Ph.D., with the Spanish National Cancer Research Center in ...
    ... MINNEAPOLIS, Aug. 3 Courage Center, the Minnesota-based ... Dianne Miron is their new Director of Physician Services effective ... physician practice, Rehab Medicine Associates, as well as finalize business ... Center. , , Miron comes to Courage ...
    ... , , , ST. LOUIS, ... tools such as Facebook, Twitter and YouTube are being used by ... Now, Anthem Blue Cross and Blue Shield members can add these ... insurer. In an effort to remain engaged and responsive to its ...
    ... The AMERIGROUP Foundation today announced it is honoring Craig Parson, ... him a "Healthy Hero." , , In ... attack, he decided to change his life and start helping others. ... bags of groceries has blossomed into a massive operation that helps ...
    Cached Medicine News:Health News:Exercise is healthy for mom and child during pregnancy 2Health News:Anthem Blue Cross and Blue Shield in Missouri Harnesses Social Media to Interact with Members 2Health News:Anthem Blue Cross and Blue Shield in Missouri Harnesses Social Media to Interact with Members 3Health News:AMERIGROUP Foundation Honors Warehouse of Hope Founder Craig Parson as a 'Healthy Hero' 2
    ... D-Type can combine a number of ... microplates on a simple to use ... is a multifunctional stand-alone device but ... robotic systems. Custom and standard add-on ...
    Grab one and go, One of the smallest handheld oximeters available, Datex-Ohmeda s TuffSat is the ideal spot-check solution for hospital, home care, transport, and EMS. TuffSat comes fully loaded wi...
    Smith & Nephew's CDS System is developed exclusively for discography., Developed exclusively for discography, it is the first system designed to measure true disc pressure and record real-time proce...
    The Maxi-Therm® lite hyper-hypothermia water blankets from Cincinnati Sub-Zero take conductive warming and cooling therapy to a new, softer level. These blankets are soft, lightweight, and remai...
    Medicine Products: